genOway’s live webinar

‍

Tuesday, November 3, 2026 - 5:30 pm CET / 11:30 am EST / 8:30 am PST

Presenter: Emily Girard, Staff Scientist, James Olson Lab - Seattle Children’s Research Institute

Title: "De-risking a PD-L1 Targeting T-cell Engager with Preclinical Mouse Models"

プレゼンテーションの主なポイント：

• A PD-L1:CD3 TCE has shown remarkable activity against intracranial xenografts in preclinical models
• genO-hPD-1/hPD-L1 mice allowed tolerability assessment of a unique PD-L1 binding protein
• genO-panhCD3 mice enabled promotion of a novel CD3 binder

Register here!‍